Purchase Short-Term Access

Review: Recombinant human erythropoietin decreases the need for blood transfusions and may delay dialysis in chronic renal failure

Steven Fishbane, MD

Annals of Internal Medicine 2002;136:85. doi:10.7326/ACPJC-2002-136-3-085

Purchase Online access to this article for 24 hours

Annals of Internal Medicine

Forgot Your Password?

to gain full access to the content and tools.

Learn more about subscription options

Forgot your password?

Enter your username and email address. We'll send you a reminder to the email address on record.

Username* (Required)

Email Address* (Required)